U.S. Metastatic Prostate Cancer Diagnoses Increase After Reduction in PSA Screening
A reduction in prostate-specific antigen (PSA) screening in men aged 40 years and older was associated with an increase in... Read More
ESMO: When to Order Next-Gen Cancer Sequencing
New recommendations for using next-generation sequencing in the setting of metastastic cancer have been published by the European Society for... Read More
PSA and Prostate Ca Metastases: The Task at Hand
Prostate cancer is the most commonly diagnosed cancer in US men, with an estimated 161,360 new cases and 26,730 deaths... Read More
Germline BRCA2-Mutant Prostate Cancer Similar to Metastases
Localized tumors from men with deleterious BRCA2 mutations were genetically more similar to metastatic cancer than to localized sporadic cancer... Read More